Seed Testing May Predict Levodopa Response in Parkinson’s
TL;DR: A 2026 medRxiv preprint found that alpha-synuclein seed-positive Parkinson’s patients had slower ON-medication motor progression, measured while usual Parkinson’s medication was active, and more sustained levodopa responsiveness than matched seed-negati…
Read article